Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Bilgin DEMİR"'
Autor:
Neslihan Özyurt, Ali Alkan, Burcu Gülbağcı, Mustafa Seyyar, Esra Aydın, Mustafa Şahbazlar, Mehmet Türker, Oğuzcan Kınıkoğlu, Tahir Yerlikaya, Gülhan Dinç, Ali Aytaç, Ziya Kalkan, Senar Ebinç, İlkay Gültürk, Merve Keskinkılıç, Zehra Sucuoğlu İşleyen, Dilek Çağlayan, Alper Türkel, Teoman Şakalar, Serhat Sekmek, Nilgün Yıldırım, Sinem Koçak, Kerem Okutur, Ahmet Özveren, Bengü Dursun, Sait Kitaplı, Orhan Önder Eren, İsmail Beypınar, İlhan Hacıbekiroğlu, Devrim Çabuk, Elanur Karaman, Ömer Acar, Semra Paydaş, Melek Karakurt Eryılmaz, Bilgin Demir, Zeynep Oruç, Mesut Yılmaz, Fatih Selçuk Biricik, Derya Kıvrak Salim, Özgür Tanrıverdi, Mutlu Doğan
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract The studies evaluating the impact of Her2 levels in neoadjuvant setting have conflicting data. The aim of the study was to evaluate the prognostic impact of Her2 status in early triple negative breast cancer(TNBC). In the study TNBC patients
Externí odkaz:
https://doaj.org/article/ce3cface4e834236bebf941d34a5f4df
Autor:
Seda Kahraman, Serdar Karakaya, Muhammed Ali Kaplan, Sema Sezgin Goksu, Akin Ozturk, Zehra Sucuoglu Isleyen, Jamshid Hamdard, Sedat Yildirim, Tolga Dogan, Selver Isik, Abdussamet Celebi, Burcu Belen Gulbagci, Nail Paksoy, Mutlu Dogan, Haci Mehmet Turk, Ahmet Bilici, Ali Murat Tatli, Sinem Akbas, Nedim Turan, Ilhan Hacibekiroglu, Gamze Gokoz Dogu, Adnan Aydiner, Ahmet Taner Sumbul, Serap Akyurek, Merih Yalciner, Ahmet Demirkazik, Pinar Gursoy, Musa Baris Aykan, Elif Sahin, İbrahim Karadag, Osman Kostek, Muhammed Muhiddin Er, Mehmet Artaç, Yakup Duzkopru, Dincer Aydin, Deniz Isik, Yusuf Karakas, Saadettin Kilickap, Cihan Erol, Bilgin Demir, Burak Civelek, Yakup Ergun, Muhammed Bulent Akinci, Izzet Dogan, Nuri Karadurmus, Perran Fulden Yumuk, Mehmet Ali Nahit Sendur
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Central nervous system (CNS) metastases can be seen at a rate of 30% in advanced stages for patients with non-small cell lung cancer (NSCLC). Growing evidence indicates the predictive roles of driver gene mutations in the development of brai
Externí odkaz:
https://doaj.org/article/dfd4fc84465f4b4985707fa241e217b7
Autor:
Olcun Umit Unal, Seval Akay, Huseyin Salih Semiz, Murat Keser, Gonul Demir, Zeliha Guzeloz Capar, Erkut Demirciler, Tugba Yavuzsen, Serkan Degirmencioglu, Bilgin Demir, Esin Oktay, Meltem Demirtas Gulmez, Mehmet Emin Arayici
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Background & aimsPrognostic factors of metastatic rectal cancer are not well known. We aim to determine prognostic factors affecting survival for metastatic rectal cancer patients and also to investigate the effect of tumor localization on overall su
Externí odkaz:
https://doaj.org/article/dfd37b3cc12c42648d63797f13af778a
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
IntroductionSeveral prognostic factors have been identified in patients with metastatic bladder cancer (BC). As it is known, older adult patients are prone to nutritional deficiency. The knowledge about nutrition and impact on survival in older patie
Externí odkaz:
https://doaj.org/article/fdbd29f4ad83433ab035c31aab986149
Publikováno v:
Erciyes Medical Journal, Vol 42, Iss 2, Pp 218-222 (2020)
Objective: This study aimed to reveal the impact of the selected healthcare spending indicators on the selected health outcomes for OECD countries. Methods: In the study, the data for OECD countries were analyzed by a stepwise multiple regression ana
Externí odkaz:
https://doaj.org/article/d7ff384071c64424b1ee46dcb84ff52b
Publikováno v:
Dicle Tıp Dergisi. :51-59
Objectives: Pancreatic cancer (PC) is one of the cancers with the worst prognosis in the world. Despite protooncogenes such as BRCA and PALB2 , effective, inexpensive, and simple methods for predicting the prognosis of patients with metastatic PC are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfb6333ecd2a5ef8748320ccd6272c00
https://doi.org/10.5798/dicletip.1266716
https://doi.org/10.5798/dicletip.1266716
Autor:
Ibrahim Karadag, Serdar Karakaya, Tolga Akkan, Bilgin Demir, Ertugrul Gazi Alkurt, Mutlu Dogan
Publikováno v:
Cancer Management and Research. 15:311-317
Ibrahim Karadag,1 Serdar Karakaya,2 Tolga Akkan,3 Bilgin Demir,4 Ertugrul Gazi Alkurt,5 Mutlu Dogan6 1Department of Medical Oncology, Hitit University Erol Olcok Training and Research Hospital, Corum, Turkey; 2Department of Medical Oncology, Health S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bad5a6f1334cea1fd00c00fb2ede8a7
https://doi.org/10.2147/cmar.s403445
https://doi.org/10.2147/cmar.s403445
Publikováno v:
Online Academic Journal of Information Technology, Vol 8, Iss 30, Pp 291-303 (2017)
Günümüzde teknolojinin gelişmesiyle birlikte İnternet hayatın her alanında yer almaya başlamıştır. Örgütlerde de çalışanlar tarafından İnternetin yaygın şekilde kullanımı iletişim kanallarını güçlendirmiş, işleri hızland
Externí odkaz:
https://doaj.org/article/ad2f2e503d3949849d7ea47b3833797c
Autor:
Ferhat, Ekinci, Onur Yazdan, Balcik, Bilgin, Demir, Pinar, Gursoy, Ahmet, Ozveren, Atike Pinar, Erdogan
Publikováno v:
Journal of the College of Physicians and Surgeons Pakistan. 32:996-1003
To evaluate the prognostic significance of the new index designed by formulating neutrophil, lymphocyte, and platelet counts in patients with metastatic disease receiving immune checkpoint inhibitors (ICI) and its effect on the immune-related adverse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1897fc0de1f043b7cea58cfb456204e4
https://doi.org/10.29271/jcpsp.2022.08.996
https://doi.org/10.29271/jcpsp.2022.08.996
Autor:
Mustafa Gürbüz, Yasin Kutlu, Erman Akkuş, Elif Berna Köksoy, Naziyet Köse, Bala Başak Öven, Başak Oyan Uluç, Atike Gökçen Demiray, Dilek Erdem, Bilgin Demir, Nazım Serdar Turhal, Necdet Üskent, Sinem Akbaş, Fatih Selçukbiricik, Ali İnal, Ahmet Bilici, Ömer Fatih Ölmez, Devrim Çabuk, Çağlar Ünal, Mutlu Hızal, Mehmet Ali Nahit Şendur, Mustafa Korkmaz, Nuri Karadurmuş, İsmail Ertürk, Sema Sezgin Göksu, Ali Murat Tatlı, Deniz Can Güven, Saadettin Kılıçkap, Nail Paksoy, Adnan Aydıner, Havva Yeşil Çınkır, Özlem Özkul, Akın Öztürk, Sevinç Ballı, Yasemin Kemal, Atike Pınar Erdoğan, Özlem Er, Perran Fulden Yumuk, Ahmet Demirkazık
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 148:3547-3555
Purpose Atezolizumab has been shown to be effective and safe in randomized trial in the first-line treatment of extensive-stage small cell lung cancer (SCLC). However, there are limited real-life data on atezolizumab. In this study, we aimed to deter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a345459815bcd72a8a16fb661d35462
https://doi.org/10.1007/s00432-022-04087-x
https://doi.org/10.1007/s00432-022-04087-x